BIONTECH
Summary
BioNTech is a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases.
Deals Overview
Total Deals11
Valued Deals8
Total Value£ 2.96 B
Avg. Deal Size£ 370 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
